139 related articles for article (PubMed ID: 38577139)
1. Identification of Genetic Variants in Exon 4 of TP53 in Lung Carcinoma and in Silico Prediction of Their Significance.
Prasad R; Sharma K; Bhutani K; Prasad S; Manhas S; Kishan J
Indian J Clin Biochem; 2024 Apr; 39(2):276-282. PubMed ID: 38577139
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide variations of
Bukovac A; Kafka A; Hrašćan R; Vladušić T; Pećina-Šlaus N
Mol Clin Oncol; 2019 Dec; 11(6):563-572. PubMed ID: 31692929
[TBL] [Abstract][Full Text] [Related]
3. Identification of h-TERT Promoter Mutations in Germline DNA from North Indian Lung Carcinoma Patients.
Prasad R; Panchal S; Rani I; Kishan J; Parashar G
Indian J Clin Biochem; 2023 Jan; 38(1):120-127. PubMed ID: 36684496
[TBL] [Abstract][Full Text] [Related]
4. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
[TBL] [Abstract][Full Text] [Related]
5. Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Wang Y; Kringen P; Kristensen GB; Holm R; Baekelandt MM; Olivier M; Skomedal H; Hainaut P; Tropé CG; Abeler VM; Nesland JM; Børresen-Dale AL; Helland A
Hum Mutat; 2004 Jul; 24(1):21-34. PubMed ID: 15221786
[TBL] [Abstract][Full Text] [Related]
6. TP53 codon 72 polymorphism and type 2 diabetes: a case-control study in South Indian population.
Punja HK; Nanjappa DP; Babu N; Kalladka K; Shanti Priya Dias B; Chakraborty G; Rao SM; Chakraborty A
Mol Biol Rep; 2021 Jun; 48(6):5093-5097. PubMed ID: 34181170
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
8. Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients.
Nairuz T; Bushra YU; Kabir Y
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3809-3815. PubMed ID: 34967559
[TBL] [Abstract][Full Text] [Related]
9. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
[TBL] [Abstract][Full Text] [Related]
10. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
Dastjerdi MN
Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma.
Khayat AS; Lobo Gatti L; Moura Lima E; de Assumpção PP; Nascimento Motta FJ; Harada ML; Casartelli C; Marques Payão SL; Cardoso Smith MA; Burbano RR
Clin Exp Med; 2005 Dec; 5(4):161-8. PubMed ID: 16362795
[TBL] [Abstract][Full Text] [Related]
12.
Cavic M; Spasic J; Krivokuca A; Boljevic I; Kuburovic M; Radosavljevic D; Jankovic R
J Clin Pathol; 2019 Jan; 72(1):75-80. PubMed ID: 30467244
[TBL] [Abstract][Full Text] [Related]
13. TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses.
Lin HY; Huang CH; Wu WJ; Chang LC; Lung FW
Int J Biomed Sci; 2008 Dec; 4(4):248-54. PubMed ID: 23675098
[TBL] [Abstract][Full Text] [Related]
14. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
15. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Functional Significance of TP53 Exon 4-Intron 4 Splice Junction Variants.
Pinto EM; Maxwell KN; Halalsheh H; Phillips A; Powers J; MacFarland S; Walsh MF; Breen K; Formiga MN; Kriwacki R; Nichols KE; Mostafavi R; Wang J; Clay MR; Rodriguez-Galindo C; Ribeiro RC; Zambetti GP
Mol Cancer Res; 2022 Feb; 20(2):207-216. PubMed ID: 34675114
[TBL] [Abstract][Full Text] [Related]
17. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
[TBL] [Abstract][Full Text] [Related]
18. Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants.
Deben C; Van den Bossche J; Van Der Steen N; Lardon F; Wouters A; de Beeck KO; Hermans C; Jacobs J; Peeters M; Van Camp G; Rolfo C; Deschoolmeester V; Pauwels P
Tumour Biol; 2017 Feb; 39(2):1010428317694327. PubMed ID: 28240049
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.
Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK
Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371
[TBL] [Abstract][Full Text] [Related]
20. The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer.
Escudeiro C; Pinto C; Vieira J; Peixoto A; Pinto P; Pinheiro M; Santos C; Guerra J; Lisboa S; Santos R; Silva J; Leal C; Coimbra N; Lopes P; Ferreira M; Sousa AB; Teixeira MR
Fam Cancer; 2021 Jul; 20(3):173-180. PubMed ID: 33051812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]